Sana Biotechnology, Inc. logo

Sana Biotechnology, Inc.

NASDAQ:SANA

Overview | Financials
Company Name Sana Biotechnology, Inc.
Symbol SANA
Currency USD
Price 5.93
Market Cap 1,313,512,790
Dividend Yield 0%
52-week-range 2.745 - 12
Industry Biotechnology
Sector Healthcare
CEO Dr. Steven D. Harr M.D.
Website https://www.sana.com

An error occurred while fetching data.

About Sana Biotechnology, Inc.

Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others. Its product candidates include SG295

Related Stocks

Mirum Pharmaceuticals, Inc. logo

Mirum Pharmaceuticals, Inc.

MIRM

37.37 USD

Enanta Pharmaceuticals, Inc. logo

Enanta Pharmaceuticals, Inc.

ENTA

14.71 USD

Syndax Pharmaceuticals, Inc. logo

Syndax Pharmaceuticals, Inc.

SNDX

23.22 USD

Keros Therapeutics, Inc. logo

Keros Therapeutics, Inc.

KROS

48.02 USD

Aclaris Therapeutics, Inc. logo

Aclaris Therapeutics, Inc.

ACRS

1.31 USD

REGENXBIO Inc. logo

REGENXBIO Inc.

RGNX

12.85 USD

National Research Corporation logo

National Research Corporation

NRC

23.93 USD

Kura Oncology, Inc. logo

Kura Oncology, Inc.

KURA

21.5 USD

FibroGen, Inc. logo

FibroGen, Inc.

FGEN

1.04 USD

Financials

Numbers are in millions USD

Numbers are in millions USD